Cognoa CEO and CMO Presenting at Digital Medicine & Medtech Showcase 2020 and Innovator MD Global Summit in San Francisco

PALO ALTO, Calif.- January 6, 2020—Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that senior executives will be speaking at two healthcare innovation and investor conferences in San Francisco. ● Brent Vaughan, CEO and co-founder of Cognoa, will provide an update on the company’s milestones and strategy at the Digital Medicine & Medtech Showcase™ 2020,…

Cognoa Wins 2019 Fierce Innovation Life Science Award

Palo Alto, Calif., December 18, 2019 –  Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Science Award for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity to receive treatments earlier when they can have the greatest impact. Currently, diagnosis and treatment of behavioral…

children looking at globe

Closing the Gaps in Pediatric Behavioral Health

Currently, most pediatricians choose to refer children to a specialist to be diagnosed and treated for behavioral conditions such as autism — often with waitlists of a year to three years. Nationwide, we continue to face an enormous and growing shortage of specialists, so the heartbreaking reality for most children and families is delayed diagnosis and late access to treatments.…

Cognoa Selected as Finalist in Fierce Innovation Awards – LifeSciences Edition 2019

Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children Palo Alto, Calif., December 5, 2019 –  Cognoa, a company at the forefront of pediatric behavioral health, announced today that it has been selected as a finalist in Questex’s Fierce Innovation Awards – LifeSciences Edition 2019, a…

cognoa-logo

Cognoa Appoints Seasoned Biotech Executive as CFO

James Welch brings two decades experience scaling high-growth companies to Cognoa as company prepares for commercialization PALO ALTO, Calif.– December 2, 2019 –Cognoa, a company at the forefront of pediatric behavioral health, announced today that James (Jim) H. Welch has been appointed Chief Financial Officer. Welch will oversee financial planning, operations and investor relations as the company advances its digital…

cognoa-logo

Cognoa to Participate in BTIG DIGITAL HEALTH and EVERCORE ISI HealthCONx Conferences.

Palo Alto, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking at two upcoming investor conferences: BTIG Digital Health 2019: Industry Innovators on What’s Next. Panel entitled, “Developing Commercial Models for Prescription Digital Therapeutics” on Wednesday, November 20 at 1:35 p.m. Eastern Time in New…

Brent Vaughan, CEO

Digital Therapeutics in Pediatric Behavioral Health — A unique opportunity to improve the standard of care and lifelong outcomes.

By Brent Vaughan, CEO and Co-Founder, Cognoa. We are experiencing a mental health crisis:one person in every four in the world will develop one or more behavioral conditions during their lifetime. Today in the U.S., one in five children have a diagnosable behavioral health disorder and only 21% of those children receive needed treatment. Read full article here.

cognoa-logo

Cognoa CEO Brent Vaughan to Speak at HLTH and CNS Summit.

Palo Alto, Calif. and Orlando, Oct. 28, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking about the future of digital therapeutics at two conferences this week, HLTH and CNS Summit. Andy Molnar, Vice President of Commercialization at Cognoa will also speak at HLTH about reimbursement strategies…

Location

Social